Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application
- 31 December 1995
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 55 (3-4) , 395-403
- https://doi.org/10.1016/0960-0760(95)00214-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: Direct and indirect estrogen effectsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Regulation of hepatic angiotensinogen synthesis and secretion by steroid hormonesEndocrinology, 1992
- Glucocorticoid- and estrogen-responsive elements in the 5???-flanking region of the rat angiotensinogen geneJournal Of Hypertension, 1991
- Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implicationsAmerican Journal of Obstetrics and Gynecology, 1990
- Estrogen therapy and liver function—metabolic effects of oral and parenteral administrationThe Prostate, 1989
- Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiolAmerican Journal of Obstetrics and Gynecology, 1985
- Antagonistic Action of Estrogens, Flutamide, and Human Growth Hormone on Androgen-Induced Changes in the Activities of Some Enzymes of Hepatic Steroid Metabolism in the Rat*Endocrinology, 1983
- Comparison of pharmacodynamic properties of various estrogen formulationsAmerican Journal of Obstetrics and Gynecology, 1982
- Time-Studies of the Changes in the Sex-Dependent Activities of Enzymes of Hepatic Steroid Metabolism in the Rat during Oestrogen AdministrationHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1979
- THE EFFECT OF THE ADMINISTRATION OF ESTROGENS ON THE RENIN-SUBSTRATE (HYPERTENSINOGEN) CONTENT OF RAT PLASMAEndocrinology, 1952